Jupizomib 2 Injection
Marketer
Jupiter Formulations Private Limited
Salt Composition
Bortezomib (2mg)
Overview Jupizomib 2 Injection
Jupizomib 2 Injection is indicated for multiple myeloma and mantle cell lymphoma. Its mechanism of action involves inhibiting or decelerating cancerous cell proliferation. Administration is exclusively via injection by a healthcare professional. Dosage and frequency are determined by your physician, contingent upon your specific condition and may be adjusted. Adhere strictly to your doctor's prescribed regimen; incorrect usage or overdosage may lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, potentially requiring weeks or months; discontinue only under medical direction. Common side effects include fatigue, nausea, emesis, and anorexia. Increased daily fluid intake may be recommended. Operation of machinery or driving should be avoided due to potential drowsiness and dizziness. This medication can reduce blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests are essential to monitor blood cell levels, as well as cardiac, hepatic, and uric acid parameters. Pre-treatment consultation with your physician is crucial if you have pre-existing liver, kidney, heart conditions, or bleeding disorders. Report any cognitive symptoms, such as memory impairment or difficulty concentrating, to your doctor immediately. Inform your healthcare provider of all concurrent medications, as interactions are possible. This medication is contraindicated during pregnancy and lactation; effective contraception is mandatory for both partners throughout treatment.
Uses of Jupizomib 2 Injection
Myeloma and mantle cell lymphoma
Major Benefits of Jupizomib 2 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Jupizomib 2 Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Jupizomib 2 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Jupizomib 2 Injection works:
Jupizomib 2 Injection is an anticancer agent that inhibits the cellular breakdown of proteins. This accumulation of proteins within cancer cells ultimately triggers their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Jupizomib 2 Injection and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Jupizomib 2 Injection during pregnancy poses a confirmed risk to fetal development, precluding its routine use. In exceptional, life-threatening circumstances, a physician might consider prescription if the potential advantages outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Jupizomib 2 Injection while breastfeeding poses a significant safety risk. Evidence indicates potential infant harm due to the drug's toxicity.
DrivingUNSAFE
Administering Jupizomib 2 Injection may induce adverse reactions impairing driving capabilities. These reactions can include fatigue, vertigo, syncope, or visual disturbances, potentially affecting safe operation of a vehicle.
KidneyCAUTION
Patients with severe renal impairment should receive Jupizomib 2 Injection with close monitoring. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should receive Jupizomib 2 Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised.
What if you forget to take Jupizomib 2 Injection :
Should you forget a scheduled Jupizomib 2 Injection, seek medical advice.
Facts to Know About Jupizomib 2 Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylalanine-based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |



